![Thomas DesRosier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas DesRosier
General Counsel bei
SERES THERAPEUTICS, INC.
Vermögen: 58 223 $ am 31.05.2026
Profil
Thomas J.
DesRosier is currently Director at Avanir Pharmaceuticals, Inc., Director at Optimer Pharmaceuticals LLC since 2013, and Chief Legal Officer & Executive Vice President at Seres Therapeutics, Inc. since 2016.
Former positions include Director at Trius Therapeutics, Inc.; Assistant General Counsel-Patents at Wyeth LLC; Chief Patent Counsel & Vice President at Genetics Institute LLC; Secretary, Chief Legal & Administrative Officer at ARIAD Pharmaceuticals, Inc. from 2015 to 2016; Secretary, Chief Legal & Administrative Officer at Cubist Pharmaceuticals LLC from 2013 to 2015; Chief Legal Officer, SVP & General Counsel at Genzyme Corp.
from 1999 to 2011; Senior Vice President & General Counsel at Sanofi from 2011 to 2013; and Principal roles at Wyeth Pharmaceuticals LLC, Lantheus Medical Imaging, Inc., and Dupont De Nemours & Co., Inc. Education includes undergraduate studies at the University of Vermont and graduate studies at Wake Forest University School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.05.2026 | 7’954 ( 0.08% ) | 58 223 $ | 31.05.2026 |
Aktive Positionen von Thomas DesRosier
| Unternehmen | Position | Beginn |
|---|---|---|
| SERES THERAPEUTICS, INC. | General Counsel | 16.05.2016 |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Direktor/Vorstandsmitglied | 24.10.2013 |
Ehemalige bekannte Positionen von Thomas DesRosier
| Unternehmen | Position | Ende |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Verwaltungsdirektor | 01.01.2016 |
| CUBIST PHARMACEUTICALS INC | Verwaltungsdirektor | 22.01.2015 |
| SANOFI | General Counsel | 01.01.2013 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | General Counsel | 01.01.2011 |
| AVANIR PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | - |
Ausbildung von Thomas DesRosier
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
76
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Develops and manufactures radio diagnostics | Health Technology |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Dupont De Nemours & Co., Inc.
 Dupont De Nemours & Co., Inc. Agricultural Commodities/MillingProcess Industries Manufactures hybrid corn and soybean seeds | Process Industries |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Wake Forest University School of Law
 Wake Forest University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
